Increased psoriasis risk found in cancer patients treated with immune checkpoint inhibitors
Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients with cancer undergoing immune checkpoint inhibitor (ICI) treatments, with implications …